ThermoGenesis and GE Healthcare complete new distribution agreement

ThermoGenesis Corp (Nasdaq: KOOL | Quote | Chart | News | PowerRating), a supplier of products for processing and storing adult stem cells, announced on Thursday that it has entered into a new enhanced distribution agreement with GE Healthcare, for its AXP AutoXpress (AXP) System used in the processing of cord blood.

Under the revised distribution contract which runs through July 2012, financial details of which were not available, GE Healthcare will continue to distribute the AXP product line, excluding certain countries in Latin and South America, Asia, CIS and Eastern Europe.

GE Healthcare will provide incremental funding for marketing support and market research beyond its previous commitments. The new arrangement also provides incentives for both parties related to sales success, product quality and delivery.